Vanda Pharmaceuticals
VNDA
VNDA
197 hedge funds and large institutions have $850M invested in Vanda Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 39 funds opening new positions, 65 increasing their positions, 67 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
1.88% less ownership
Funds ownership: 99.26% → 97.38% (-1.9%)
10% less capital invested
Capital invested by funds: $947M → $850M (-$96.3M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
197
Holding in Top 10
–
Calls
$17.8M
Puts
$4.85M
Top Buyers
| 1 | +$13.9M | |
| 2 | +$6.01M | |
| 3 | +$5.73M | |
| 4 |
Hotchkis & Wiley Capital Management
Los Angeles,
California
|
+$4.46M |
| 5 |
Two Sigma Investments
New York
|
+$3.28M |
Top Sellers
| 1 | -$33.7M | |
| 2 | -$15M | |
| 3 | -$11.7M | |
| 4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$5.07M |
| 5 |
Wells Fargo
San Francisco,
California
|
-$3.3M |